Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

TriSalus Life Sciences, Inc. (TLSI) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$11.21M
Net Income	$-9.00M
Cost of Goods Sold	$1.80M
Gross Profit	$9.41M
Operating Expenses	$18.55M
Operating Income	$-7.33M
Non-Operating Income/Expense	$-0.96M
Pre-Tax Income	$-8.29M
Normalized Pre-Tax Income	$-8.29M
Income after Taxes	$-8.29M
Income from Continuous Operations	$-8.29M
Consolidated Net Income/Loss	$-8.29M
Normalized Income after Taxes	$-8.29M
EBIT	$-7.33M
EBITDA	$-6.91M
Weighted-Average Shares Outstanding (Basic)	32.90M
Weighted-Average Shares Outstanding (Diluted)	32.90M
Earnings per Share (EPS) (Basic)	$-0.27
Earnings per Share (EPS) (Diluted)	$-0.27
Balance Sheet Financials
Current Assets	$38.08M
Property, Plant, and Equipment	$1.71M
Long-Term Assets	$3.23M
Total Assets	$41.32M
Current Liabilities	$9.32M
Long-Term Debt	$32.27M
Long-Term Liabilities	$51.42M
Total Liabilities	$60.74M
Common Equity	$-19.42M
Tangible Shareholders Equity	$-19.42M
Shareholders Equity	$-19.42M
Common Shares Outstanding	37.98M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-11.82M
Cash Flow from Investing Activities	$-0.62M
Cash Flow from Financial Activities	$30.41M
Beginning Cash	$8.88M
End Cash	$26.84M
Increase/Decrease in Cash	$17.96M
Stock-Based Compensation	$3.51M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.08
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	2.51
Debt to Equity Ratio	-1.66
Gross Margin	83.93%
Operating Margin	-65.39%
EBIT Margin	-65.39%
EBITDA Margin	--
Pre-Tax Profit Margin	-73.94%
Profit Margin	-80.28%
Free Cash Flow	$-12.44M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.27
Inventory Turnover	0.47
Receiveable Turnover	2.01
Days Sales in Receivables	44.72
Return on Equity	42.70%
Return on Tangible Equity	42.70%
Return on Assets	-20.07%
Return on Investments	-64.54%
Book Value Per Share	$-0.51
Free Cash Flow per Share	$-0.38
Operating Cash Flow per Share	$-0.36

Data from Zacks Investment Research, Inc.